NCT01753180 - Total Occlusion Study in Coronary Arteries - 5 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

July 31, 2016

Conditions

Chronic Coronary Total Occlusions

Interventions

BIOLOGICAL

collagenase

Local intra-coronary administration of MZ-004 at or into the CTO

DRUG

saline

Local intra-coronary administration of saline at or into the CTO

Trial Locations (13)

91031

Shaare Zedek Medical Center, Jerusalem

T2N 4Z6

Foothills Medical Centre, Calgary

R2H 2A6

St. Boniface Hospital, Winnipeg

L8L 2X2

Hamilton Health Sciences, Hamilton

N6A 5A5

London Health Sciences Centre, London

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

M5B 1W8

St. Michael's Hospital, Toronto

M5G 2C4

Toronto General Hospital, Toronto

H2W 1T8

CHUM Hotel Dieu, Montreal

H4J 1C5

Hopital du Sacre-Coeur de Montreal, Montreal

G1V 4G5

Centre de recherche de l'Institut Universitaire de Pulmonologie et Cardiologie de Quebec, Ste. Foy

1105 AZ

Academic Medical Center, Amsterdam

All Listed Sponsors

lead

Matrizyme Pharma Corporation

INDUSTRY